Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

5am Ventures

WebsiteLinkedInTwittercbCrunchbase
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
Industries
  • Biotechnology
  • AI
  • Health Tech
About
5AM Ventures is a leading venture capital firm founded in 2002, specializing in early-stage life science companies. With a focus on biopharmaceuticals, drug delivery technologies, and life science instruments, 5AM Ventures invests in innovative platforms advancing human health.
Min check size
$100K
Max check size
$10M
Fund size
NPS

Investment Thesis

5AM Ventures focuses on building nextgeneration life science companies. With a dedicated approach through their 4:59 initiative, They partner with academics and entrepreneurs to establish proofofconcept data, enabling Series A Financing. Their investments are aimed at generating attractive returns within three to five years, driven by validated developmentstage assets and technologies with less regulated commercialization paths. They strive to maximize shareholder returns for all portfolio companies by redefining business strategies, restructuring management teams, and accessing additional assets to enhance performance and fund returns.
Lead investor
Co Invest
Number of exits
Preferred contact method

5am Ventures Contacts Information

Primary contact

Secondary contact

Portfolio

5AM Ventures

Achaogen

Akouos

Alexza

Ambrx

Aprea

Artiva Biotherapeutics

Arvinas

Audentes

Bellerophon

Bird Rock Bio

Bioz

Cabaletta Bio

Calibrium

Camp4

Cellular Research

Ceterix Orthopedics

Chrono Therapeutics

Cidara

CinCor Pharma

Crinetics

Curie.Bio

Deverra

Dianthus Therapeutics

DVS Sciences

Enliven Therapeutics

Ensoma

Entrada Therapeutics

Envoy

Epirus

Escient Pharmaceuticals

Expansion Therapeutics

Faraday

Fellow Health

Flexion

GlycoEra

Halio

Homology Medicines

Ideaya Biosciences

Igenica

Ikaria

Ilypsa

Impel Neuropharma

Incline

Inipharm

KaloBios

Karius

Kinaset Therapeutics

Latigo Biotherapeutics

Lifordi Immunotherapeutics

Magnetic Insight

Marcadia

Miikana

Millendo

nChroma Bio

Neurogastrx

Nido Bio

NodThera

Nouscom

Novira

Panomics

Pear

Pearl

PhaseRx

Portal Instruments

Precede Biosciences

Precision NanoSystems

Pulmatrix

Purigen Biosystems

Radionetics

Rallybio

RareCyte

Relypsa

Renasant Bio

Rennovia

Scientist.com

scPharmaceuticals

Semprus Biosciences

Skye Bioscience

Surrozen

Synosia

TMRW

VBI Vaccines

Viveve

Vor Biopharma

Wildcat

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp